Axoltis Pharma’s Breakthrough in Neurodegenerative Disease Research, Supported by InSilicoTrials
Axoltis Pharma is at the forefront of developing treatments for neurodegenerative diseases, with their phase 1b clinical trial of NX210c marking a notable achievement in the field. This peptide drug candidate has shown promising results following a successful phase 1a … Read More
AI state-of-play around clinical research – BRAINTEASER Community of Practice
The life sciences sector is beginning to experience the transformative effects of AI, with numerous applications offering clinical, operational, and medical advantages. Unlike other industries, life sciences face the unique challenge of safeguarding patient safety and privacy. This has led … Read More
Cutting-edge Big Data initiative seeks to provide crucial support to people affected by Amyotrophic Lateral Sclerosis and Multiple Sclerosis
Mamede de Carvalho, a renowned neurologist and the head of the Amyotrophic Lateral Sclerosis (ALS) Clinic at Centro Hospitalar Universitário Lisboa Norte (CHULN), situated at the prestigious Hospital de Santa Maria, recently unveiled the exciting BRAINTEASER project during an exclusive … Read More
Collaboration Between InSilicoTrials and Biofarma Group Explores the Benefits of In Silico Technology in Clinical Research
InSilicoTrials has collaborated effectively with Biofarma Group to harness the potential of in silico technology for clinical research. In this collaboration, InSilicoTrials utilized its expertise in computational modeling to analyze and reinterpret the clinical trial data of Epatrex, Biofarma Group’s … Read More
Cutting-edge Big Data initiative seeks to provide crucial support to people affected by Amyotrophic Lateral Sclerosis and Multiple Sclerosis
Mamede de Carvalho, a renowned neurologist and the head of the Amyotrophic Lateral Sclerosis (ALS) Clinic at Centro Hospitalar Universitário Lisboa Norte (CHULN), situated at the prestigious Hospital de Santa Maria, recently unveiled the exciting BRAINTEASER project during an exclusive … Read More
Transforming Fracture Risk Assessment for Cancer Patients with Vertebral Metastases
Cutting-edge EU-funded project METASTRA unites an interdisciplinary team of experts to spearhead a transformative approach to revolutionize fracture risk assessment and personalized treatment for cancer patients with vertebral metastases. A groundbreaking initiative, METASTRA is set to transform the way clinicians … Read More
Unleashing the IDPP@CLEF Potential: Assessing Predictive Algorithms and Enabling Data Sharing for Enhanced Research
Each year, the BRAINTEASER project organizes an open evaluation challenge, called iDPP@CLEF (Intelligent Disease Progression Prediction), to involve research groups from academia and industry in the assessment of the performance of their AI algorithms to predict the progression of ALS … Read More
Toward Good Simulation Practice: Best Practices for the Use of Computational Modelling & Simulation in the Regulatory Process of Biomedical Products
In Silico Trials, the use of computational modelling & simulation in the development and regulatory assessments of biomedical products is an emerging practice in the biomedical industry. While the first technical standards, such as the ASME VV-40:2018, are appearing, there … Read More